Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

S&P 500 ends up, win streak at 5; Nasdaq ekes out gain even as Alphabet weighs



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-S&P 500 ends up, win streak at 5; Nasdaq ekes out gain even as Alphabet weighs</title></head><body>

S&P 500, Nasdaq extend win streaks to five

U.S. CPI rises as expected in July

Alphabet dips after report US mulls Google break-up

VIX records fastest ever drop from high-fear range

Indexes up: Dow 0.61%, S&P 500 0.38%, Nasdaq 0.03%

Adds closing prices

By David French

Aug 14 (Reuters) -The S&P 500 ended higheron Wednesday, stretching its winning streak to five sessions, as the latest inflation data reassured investors betting the Federal Reserve would start cutting U.S. interest rates next month.

The Nasdaq Composite also posted its fifth straight daily gain, although it barely scraped into positive territory asAlphabet and some megacap tech stocks weighed.

Moves were generally subdued with many investors away for August vacations, and new triggers for trading were absent, contributing to an overall listless picture among the benchmarks.

The latest U.S. consumer price data, released earlier on Wednesday, reinforced expectations that the Fed would start interest rate cuts inSeptember.

U.S. consumer prices rose moderately in July, and the annual increase in inflation slowed to below 3% for the first time since early 2021. A day earlier,softer-than-expected producer prices data indicated inflation continued to moderate, although not yet all the way to the U.S. central bank's 2% target.

Money markets now see a 55% chance of a 25-basis point (bps) rate cut at the Fed's Sept. 17-18 meeting, as per the CME FedWatch Tool. Before the data, traders were nearly evenly split between a 25-bps and 50-bps cut.

Scott Ladner, chief investment officer at Horizon Investments, said he called days such as this "markets violently going nowhere", adding with CPI painting a similar picture to PPI data, there was no reason for traders to reassess moves put in place on the previous day.

"There's no huge rationale to move prices one way or another," he said.

The S&P 500 .SPX closed at 5,455.21, up 0.38% or 20.78 points. The Nasdaq Composite .IXICclosed at 17,192.60, up 0.03% or 4.99 points. The Dow Jones Industrial Average .DJI closed up 242.75 points or 0.61% at 40,008.39.

Shares of Alphabet, the Google-parent GOOGL.O, dropped 2.3% on a media report that the U.S. Department of Justice is considering options that include breaking up the online search engine.

Other megacaps were mixed: Tesla TSLA.O slumped 3.1% andMeta Platforms dropped 0.3%, while Microsoft MSFT.O fell 0.7% andNvidia NVDA.O declined 1.7%.

A rebound in megacap and tech stocks has helped markets recoup most losses from a global market rout early this month after data showed the U.S. unemployment rate surged in July.

Thursday's release by the Commerce Department's Census Bureau of retail sales data will be keenly watched by those concerned about the overall strength of the American economy, Horizon's Ladner said.

These worries had sent the Cboe volatility index .VIX, Wall Street's fear gauge, to its highest since 2020 just last week. However, on Wednesday, it stayed below its long term average of 20 points for the second day to close at16.19.

The seven trading sessions it took the VIX to return to its long-term median of 17.6 is the index’s quickest ever drop from 35, a level associated with a high degree of fear, according to aReuters analysis.

A majority of the major S&P sectors were in positive territory, led by a 1.3% risein financials .SPSY. Its advance was aided by gains of more than 4.6% by Progressive PGR.N and Charles Schwab SCHW.N, which rose after positive July performance numbers, and Allstate ALL.N, which climbed after agreeing to sell a business unit.

Both of the insurers ended at record closing highs.

Kellanova K.N surged 7.8% afterfamily-owned candy giant Mars said it would buy the Cheez-It and Pringles maker in a nearly $36 billion deal.

Cardinal Health CAH.N gained 3.7% after the drug distributor raised its 2025 profit forecast.



Reporting by Medha Singh and Shashwat Chauhan in Bengaluru and David French in New York; Editing by Maju Samuel and David Gregorio

</body></html>

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.